Bibliographic record
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2…
Ludvik B, Giorgino F, Jódar E, Frias JP, Fernández Landó L, Brown K, Bray R, Rodríguez Á. The Lancet 2021
§1Bibliographic record
§1.1Record
- Authors
- Ludvik B, Giorgino F, Jódar E, Frias JP, Fernández Landó L, Brown K, Bray R, Rodríguez Á
- Title
- Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
- Source
- The Lancet
- Year
- 2021
- Volume, issue, pages
- 398(10300):583–598
- Digital object identifier
- 10.1016/S0140-6736(21)01443-4
- PubMed identifier
- 34370970
- Record type
- Journal article
- Institute identifier
- CEI-BR-068
§1.2Institute documents citing this record
Table 1. Documents in the Institute set that cite this record.
| Document | Series |
|---|---|
| Monograph: Tirzepatide | Compound monograph |
| 1 citing document. | |
§1.3Subject tags
tirzepatide insulin SURPASS
Compound Evidence Institute · CEI-BR-068 · https://compoundevidence.com/bibliography/ludvik2021/ · retrieved 30 July 2026